Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours Β· Estimated delivery Aug 18 - Aug 23
Russo RS, Gasperini S, Bubb G, Neuman L, Sloan LS, Diaz GA, et al
This is based on a question that asks U.S
Given the high mortality associated with APL, immediate ATRA treatment is recommended based on cytological and clinical criteria, while awaiting genetic confirmation ( In the consolidation phase, we continued ATRA combined with ATO
It is an effective TG-reducing agent and remains the only lipid modifying drug to date that reduces cardiovascular mortality over and above statin therapy
We have to reorient our approach to prioritize health and well-being
10.1016/j.yexmp.2012.04.003 158 KimW
US$ 22.57
US$ 26.26
US$ 25.35
US$ 27.13
US$ 24.78
US$ 22.90
-1.jpg&w=1200&q=75)
US$ 21.79
US$ 27.79
.webp)
US$ 22.55
US$ 28.61
US$ 26.92
US$ 22.36
